ARTICLE | Company News
ChemBridge, Merck KGaA, Pfizer deal
February 16, 2004 8:00 AM UTC
The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC will design and develop combinatorial compound libraries for PFE. The partners also enlarged the scope of the deal to include medicinal chemistry support for Pfizer Global Research and Development. ...